← All candidates
46 insider filings on record.
46 filings on record.
IBRXImmunityBio, Inc.
NasdaqGS · Healthcare · $8.56B
$8.08
-2.83% today
46 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 13 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$8.56B
Float
406.6M
38% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
51.7
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
41 more transactions on Pro →Context
Wall St
$13.00 avg target
+60.9% vs today · 3 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26−$0.08 act−$0.01
Q4 '25−$0.06 act+$0.04
Q3 '25−$0.07 act+$0.03
Q2 '25−$0.10 act+$0.00
Coverage
IBRX Stock Slips Overnight: Insider Sale Tests Retail Optimism Ahead Of FDA Growth CatalystStocktwits · 07-06IBRX Stock At 3-Month High: Retail Bulls Eye July Catalysts Around Anktiva Saudi Expansion, Q2 SalesStocktwits · 06-30ImmunityBio (IBRX) Moves 11.8% Higher: Will This Strength Last?Zacks · 06-29SLS, IBRX Eye Green Month As Biotech ETF Gains Steam: Analyst Sees ‘Continued Opportunities’ In Immuno-OncologyStocktwits · 06-29
The file stays open
46 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice